Tkg Advisors, LLC Pfizer Inc Transaction History

Tkg Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $17,025 - $19,950	-674 Reduced 0.89%	75,447 $2.11 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $647,508 - $743,547	25,010 Added 48.93%	76,121 $2.11 Million
Q4 2023 Feb 23, 2024	BUY	$26.13 - $33.94 $28,507 - $37,028	1,091 Added 2.18%	51,111 $1.47 Million
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $48,423 - $56,602	1,509 Added 3.11%	50,020 $1.66 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $1.75 Million - $2.03 Million	48,511 New	48,511 $1.78 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Tkg Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tkg Advisors, LLC with notifications on news.